Bo biotech VC surges: a16z’s $700M, Sofinnova €650M & exit risks rise
a16z raised $15B across five funds and earmar...
Europe’s biotech VC market is strengthening, ...
The fresh capital targets early and growth-st...
Despite big fundraises, exits and financing r...
Europe’s biotech VC market is strengthening, ...
The fresh capital targets early and growth-st...
Despite big fundraises, exits and financing r...










